 |
dabrafenib |
|---|---|
| Trade Name | Tafinlar |
| Orphan Indication | Metastatic Melanoma |
| USA Market Approval | USA |
| USA Designation Date | 2011-01-12 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corp.;One Health Plaza;East Hanover, New Jersey, 07936 |
| |
dabrafenib |
|---|---|
| Trade Name | Tafinlar |
| Orphan Indication | Metastatic Melanoma |
| USA Market Approval | USA |
| USA Designation Date | 2011-01-12 00:00:00 |
| Sponsor | Novartis Pharmaceuticals Corp.;One Health Plaza;East Hanover, New Jersey, 07936 |